Biologist - In Vivo at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, Neuroscience, HealthcareIndustries

Requirements

  • Bachelors or Masters Degree in Biology, Pharmacology, Animal Sciences, Neuroscience, or a related scientific field
  • 2+ years of post-degree academic or industry experience involving in vivo studies

Responsibilities

  • Design, lead, and conduct in vivo studies from initiation through data delivery, including dosing, tissue collection, and sample processing
  • Perform all core in vivo dosing techniques, including intravenous, intraperitoneal, subcutaneous, and intracerebroventricular routes
  • Master and perform rodent surgical techniques for sample collection (e.g., CSF, brain, plasma) and delivery of therapeutics
  • Execute study-specific workflows, including antibody administration, pharmacokinetic sampling, and brain dissection
  • Perform supporting biochemical assays (ELISA, Western blot, etc.) for quantification and biomarker readouts
  • Maintain accurate, organized records of experimental data, protocols, and sample inventories in electronic lab notebooks
  • Communicate study progress and data clearly to project leads and cross-functional teams
  • Ensure compliance with IACUC-approved animal protocols and uphold high standards of animal welfare and laboratory safety

Skills

Key technologies and capabilities for this role

In Vivo PharmacologyPharmacokineticsRodent StudiesMouse ModelsAntibody PKBrain PenetrationTarget EngagementTransgenic ModelsKnock-in ModelsCSF CollectionICV InjectionsTissue HarvestingSurgical ProceduresStudy DesignData Analysis

Questions & Answers

Common questions about this position

What education level is required for the Biologist - In Vivo position?

The position requires a Bachelors or Masters degree for an experienced in vivo scientist.

What are the main responsibilities of this role?

Key responsibilities include designing and conducting in vivo studies in rodent models, performing dosing techniques and surgical procedures like CSF collection and intracerebroventricular injections, executing biochemical assays, maintaining records, and communicating data to teams.

What is the salary or compensation for this position?

This information is not specified in the job description.

Is this a remote position or does it require on-site work?

This information is not specified in the job description.

What qualities make a strong candidate for this role?

The ideal candidate is highly motivated, detail-oriented, adaptable, capable of independently running high-quality in vivo studies, and maintaining excellent documentation practices.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI